Researchers find blood marker that defines which patients will respond to colorectal cancer drug

Researchers at the Princess Margaret Cancer Centre have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.